AffiliationDivision of Cancer Sciences, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK
MetadataShow full item record
AbstractThe annual global incidence of cervical cancer is approximately 604 000 cases/342 000 deaths, making it the fourth most common cancer in women. Cervical cancer is a major healthcare problem in low and middle income countries where 85% of new cases and deaths occur. Secondary prevention measures have reduced incidence and mortality in developed countries over the past 30 years, but cervical cancer remains a major cause of cancer deaths in women. For women who present with F�d�ration Internationale de Gyn�cologie et d'Obst�trique (FIGO 2018) stages IB3 or upwards, chemoradiation is the established treatment. Despite high rates of local control, overall survival is less than 50%, largely due to distant relapse. Reducing the health burden of cervical cancer requires greater individualization of treatment, identifying those at risk of relapse and progression for modified or intensified treatment. Hypoxia is a well known feature of solid tumors and an established therapeutic target. Low tumorous oxygenation increases the risk of local invasion, metastasis and treatment failure. While meta-analyses show benefit, many individual trials targeting hypoxia failed in part due to not selecting patients most likely to benefit. This review summarizes the available hypoxia-targeted strategies and identifies further research and new treatment paradigms needed to improve patient outcomes. The applications and limitations of hypoxia biomarkers for treatment selection and response monitoring are discussed. Finally, areas of greatest unmet clinical need are identified to measure and target hypoxia and therefore improve cervical cancer outcomes.
CitationDatta A, West C, O�Connor JPB, Choudhury A, Hoskin P. Impact of hypoxia on cervical cancer outcomes. International Journal of Gynecologic Cancer. BMJ; 2021. p. ijgc�2021�002806.
JournalInternational Journal of Gynecological Cancer
- Suicidal Ideation
- Authors: Harmer B, Lee S, Duong TvH, Saadabadi A
- Issue date: 2021 Jan
- Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
- Authors: Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H
- Issue date: 1995 Jul 30
- Authors: Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P, Holmes KK, Bertozzi S, Bloom BR, Jha P
- Issue date: 2017 Nov 3
- Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
- Authors: Ricciardi A, Largeron N, Giorgi Rossi P, Raffaele M, Cohet C, Federici A, Palazzo F
- Issue date: 2009 Mar-Apr
- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
- Authors: Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, Castle PE, Bray F, Canfell K
- Issue date: 2019 Mar